“This is not the future, this is already the present”: for which bacteria there will soon be no drugs
Pharmacologist Dehnich explained where "superbugs" come from
– According to recent statistics from the Ministry of Health , half of Russians take antibiotics incorrectly and are at risk of developing antibiotic resistance – including because they take medicines without a doctor’s prescription. How pronounced is the problem of bacterial resistance to antibiotics in Russia ?
The problem of antibiotic resistance is expressed all over the world. And I don’t think that in Russia it was the over-the-counter sale of antibiotics that played the main role. Our outpatient consumption of antibiotics is no higher than in other countries with a developed healthcare system.
It must be understood that antibiotic resistance knows no boundaries.
Therefore, problems that may initially appear in countries with suboptimal health systems then reach more developed countries. A typical example is when microbes appeared in India that produce the enzyme carbapenemase NDM-1, which leads to the development of resistance to carbapenems, the last line antibiotics for the treatment of the most severe infections. As a result, the problem was faced in Europe, they began to understand and found out that India became the source of resistant bacteria.
– According to recent statistics from the Ministry of Health , half of Russians take antibiotics incorrectly and are at risk of developing antibiotic resistance – including because they take medicines without a doctor’s prescription. How pronounced is the problem of bacterial resistance to antibiotics in Russia ?
The problem of antibiotic resistance is expressed all over the world. And I don’t think that in Russia it was the over-the-counter sale of antibiotics that played the main role. Our outpatient consumption of antibiotics is no higher than in other countries with a developed healthcare system.
It must be understood that antibiotic resistance knows no boundaries.
Therefore, problems that may initially appear in countries with suboptimal health systems then reach more developed countries. A typical example is when microbes appeared in India that produce the enzyme carbapenemase NDM-1, which leads to the development of resistance to carbapenems, the last line antibiotics for the treatment of the most severe infections. As a result, the problem was faced in Europe, they began to understand and found out that India became the source of resistant bacteria.
